picrotoxin has been researched along with Cognition Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Dillon, GH; Forster, MJ; Huang, R; Li, W; Liu, R; Rutledge, M; Shetty, RA; Simpkins, JW; Sumien, N; Thangthaeng, N; Yang, SH; Yuan, F | 1 |
| Björefeldt, A; Blomgren, K; Carlström, KE; Daborg, J; Ekdahl, CT; Hanse, E; Kalm, M; Pekna, M; Perez-Alcazar, M; Stokowska, A; Wasling, P; Zetterberg, H | 1 |
| Underwood, E | 1 |
| Furudate, H; Kimura, T; Mizoroki, T; Murayama, M; Takashima, A; Yamashita, S; Yoshiike, Y | 1 |
| Mucke, L; Palop, JJ | 1 |
| Belichenko, PV; Epstein, CJ; Kleschevnikov, AM; Malenka, RC; Mobley, WC; Villar, AJ | 1 |
| Blank, M; Fernandez, F; Garner, CC; Malenka, RC; Morishita, W; Nguyen, J; Zuniga, E | 1 |
| Cattabeni, F; De Graan, PN; Di Luca, M; Gispen, WH; Ramakers, GM; Urban, IJ | 1 |
1 review(s) available for picrotoxin and Cognition Disorders
| Article | Year |
|---|---|
Epilepsy and cognitive impairments in Alzheimer disease.
Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Apolipoprotein E4; Brain; Cognition Disorders; Dentate Gyrus; Disease Models, Animal; Electroencephalography; Epilepsy; GABA Antagonists; Genetic Carrier Screening; Hippocampus; Humans; Mice; Mice, Transgenic; Nerve Net; Neural Inhibition; Picrotoxin; Synaptic Transmission; tau Proteins | 2009 |
7 other study(ies) available for picrotoxin and Cognition Disorders
| Article | Year |
|---|---|
Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model.
Topics: Animals; Central Nervous System Stimulants; Cognition Disorders; Disease Models, Animal; Excitatory Postsynaptic Potentials; Functional Laterality; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Infarction, Middle Cerebral Artery; Male; Maze Learning; Membrane Proteins; Motor Activity; Nerve Tissue Proteins; Picrotoxin; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Visual Perception | 2013 |
Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3.
Topics: Animals; Animals, Newborn; Avoidance Learning; Cognition Disorders; Complement C3; Disease Models, Animal; Dizocilpine Maleate; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Net; Neurons; Picrotoxin; Synapses; Ultrasonography; Valine | 2014 |
Can Down syndrome be treated?
Topics: Adult; Animals; Brain; Child; Chromosomes, Human, Pair 21; Clinical Trials as Topic; Cognition Disorders; Down Syndrome; Early Medical Intervention; Female; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Male; Mice; Mutagenesis, Insertional; Picrotoxin; RNA, Long Noncoding | 2014 |
GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin.
Topics: Aging; Amyloid beta-Protein Precursor; Animals; Cognition Disorders; GABA Antagonists; Humans; Learning; Long-Term Potentiation; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Picrotoxin; Presenilin-1; Receptors, GABA-A | 2008 |
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cognition Disorders; Crosses, Genetic; Dentate Gyrus; Disease Models, Animal; Down Syndrome; Evoked Potentials; Female; GABA-A Receptor Antagonists; Gene Dosage; Glycine; Hippocampus; Long-Term Potentiation; Magnesium; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Mutant Strains; Patch-Clamp Techniques; Picrotoxin; Presynaptic Terminals; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Species Specificity; Trisomy | 2004 |
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.
Topics: Animals; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Down Syndrome; Electric Stimulation; Excitatory Postsynaptic Potentials; Exploratory Behavior; Female; GABA Antagonists; Hippocampus; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Neurons; Pentylenetetrazole; Picrotoxin | 2007 |
The impaired long-term potentiation in the CA1 field of the hippocampus of cognitive deficient microencephalic rats is restored by D-serine.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Cognition Disorders; Electric Stimulation; Electrophysiology; Hippocampus; In Vitro Techniques; Kynurenic Acid; Picrotoxin; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serine; Synapses; Synaptic Transmission; Time Factors | 1993 |